A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.

Clinical trial NCT00405756 · COMPLETED

Trial details

NCT number: NCT00405756
Sponsor: Celgene Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Newly Diagnosed Multiple Myeloma

Start date: 2007-01-01
Primary completion: 2009-11-01
Enrollment: 459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.